Crowdonomics
All companies

HEALTHY EXTRACTS INC.

Public

Biotech · Henderson, NV

Latest valuation
—
No round has disclosed a priced valuation or cap.
Total raised
$100,000
Crowd $0 · Private $100K · 3 rounds since 2015
Latest share price
$0.00
Reg A Offering (2021) offering price

Financials

FY2014–FY2025 · from SEC filings · hover any figure for its source
$67K
−$3.3M
2018
$748K
$633K
2019
$1.3M
−$2.6M
2020
$1.7M
−$2.0M
2021
$2.3M
−$983K
2022
$2.5M
−$2.5M
2023
$3.1M
−$841K
2024
$4.5M
−$881K
2025
RevenueNet income — beside revenue when positive, below the line when a loss

Chart shows the most recent 8 fiscal years; 4 earlier years are in the table below.

Metric
FY2014 audited
FY2015 audited
FY2016 audited
FY2017 audited
FY2018 audited
FY2019 audited
FY2020 audited
FY2021 audited
FY2022 audited
FY2023 audited
FY2024 audited
FY2025 audited
Income statement
Revenue
—
$115,551
$162,750
$128,105
$67,131
$748,377
$1,276,559
$1,676,598
$2,251,469
$2,485,866
$3,113,279
$4,511,997
Cost of goods sold
—
$46,626
$26,933
$43,648
$28,590
$524,494
$1,855,001
$346,156
$783,141
$864,055
$1,201,959
$2,089,506
Gross margin
—
60%
83%
66%
57%
30%
-45%
79%
65%
65%
61%
54%
Net income
—
-$730,872
-$3,370,935
-$3,562,075
-$3,329,517
$632,776
-$2,576,375
-$1,987,122
-$983,121
-$2,472,931
-$840,671
-$881,119
Taxes paid
—
—
—
—
—
—
—
—
$0
$0
$0
$0
Balance sheet
Cash
$733
$1,536
$24,102
$81,653
$485
$133,451
$59,201
$222,098
$65,651
$19,441
$112,020
$146,935
Accounts receivable
—
$44,000
$66,000
$16,000
—
$26,473
$13,274
$133,340
$105,794
$30,440
$11,003
$187,750
Total assets
$733
$155,123
$146,183
$1,122,743
$85,768
$3,449,526
$3,115,430
$3,029,579
$2,781,118
$2,635,014
$2,377,973
$27,824,664
Short-term debt
—
—
—
—
$63,000
$79,667
—
$0
$275,370
$361,093
$2,427
$1,246,670
Long-term debt
—
—
—
—
—
$0
$0
—
—
—
—
—
Total liabilities
—
$25,152
$2,505,602
$2,301,870
$3,649,984
$4,315,136
$261,604
$0
$275,370
$361,093
$1,967,596
$3,795,099
Other
Headcount
—
—
—
—
—
2
2
—
—
—
—
—

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Cap table

Share counts as of Jun 30, 2026
ClassOutstandingVotes / shareShare of totalLast price
Common stock14,741,348—100.0%—

Shares outstanding over timein today's share terms

17M8.4M0
Apr 2017Jun 2026
Common stockPreferred StockRound openedSplit / conversion

Principal holders% as the filing states it, Apr 9, 2026

  • Kevin "Duke" Pitts304,838 shares1.8%of company
  • Bill Croyle31,948 shares1%of company
  • Robert Madden125,929 shares1%of company
  • William Bossung64,245 shares1%of company

From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.

Fundraising history

Team

3 people
Kevin “Duke” Pitts
President, Director (2018)
William Bossung
Secretary, Chief Financial Officer, Director (2014)
Bill Croyle
Director (2019)

Names and titles as disclosed on SEC Form 1-A. Bios and photos come from the platform campaign page and may be out of date.

  • Form 10-QAug 14, 20260001096906-26-001237
    EDGAR
  • Form 10-QMay 14, 20260001096906-26-000791
    EDGAR
  • Form 10-KApr 9, 20260001096906-26-000515
    EDGAR
  • Form 10-QNov 14, 20250001096906-25-001864
    EDGAR
  • Form 10-QAug 13, 20250001096906-25-001303
    EDGAR
  • Form 10-QMay 13, 20250001096906-25-000753
    EDGAR
  • Form 10-K/AApr 22, 20250001096906-25-000553
    EDGAR
  • Form 10-KApr 1, 20250001096906-25-000370
    EDGAR
Source: SEC EDGARCIK 0001630176NVShare price $0.00Last synced Aug 16, 2026

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.